Xuyong Wei
Overview
Explore the profile of Xuyong Wei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
109
Citations
1021
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Xu C, Fang X, Lu B, Song Y, Shu W, Lu Z, et al.
Cell Biochem Funct
. 2024 Jun;
42(4):e4040.
PMID: 38850132
Liver ischemia-reperfusion injury (IRI) is an important factor affecting the prognosis of liver transplantation, and extended criteria donors (e.g., steatosis donor livers) are considered to be more sensitive to ischemia-reperfusion...
22.
Yang M, Wei X, Shu W, Zhai X, Zhou Z, Cai J, et al.
Int J Surg
. 2024 Jun;
110(9):5652-5661.
PMID: 38847771
Background And Aims: The practice of intraoperative blood salvage and autotransfusion (IBSA) during deceased donor liver transplantation for hepatocellular carcinoma (HCC) can potentially reduce the need for allogeneic blood transfusion....
23.
Shu W, Song Y, Lin Z, Yang M, Pan B, Su R, et al.
Heliyon
. 2024 May;
10(10):e30964.
PMID: 38803961
Background: Accurate evaluation of postoperative liver regeneration is essential to prevent postoperative liver failure. Aims: To analyze the predictors that affect liver regeneration after hemi-hepatectomy. Method: Patients who underwent hemi-hepatectomy...
24.
Wang K, Yan L, Qiu X, Chen H, Gao F, Ge W, et al.
Biochim Biophys Acta Mol Basis Dis
. 2024 May;
1870(6):167236.
PMID: 38740225
Pancreatic ductal adenocarcinoma (PDA) is a common malignancy with a 5-year survival <10 %. Immunosuppressive tumor microenvironment (TME) plays a critical role in the progression of PDA. In recent years,...
25.
Xiang Z, Li J, Zeng H, Xiang X, Gao F, Wang K, et al.
Aging Dis
. 2024 Apr;
16(2):1036-1058.
PMID: 38607739
End-stage liver disease (ESLD), stemming from a spectrum of chronic liver pathologies including chronic liver failure, acute cirrhosis decompensation and hepatocellular carcinoma, imposes a significant global healthcare burden. Liver transplantation...
26.
Hu X, Chen G, Huang Y, Cheng Q, Zhuo J, Su R, et al.
Adv Sci (Weinh)
. 2024 Feb;
11(16):e2306915.
PMID: 38357830
Recent studies suggest that circular RNA (circRNA)-mediated post-translational modification of RNA-binding proteins (RBP) plays a pivotal role in metastasis of hepatocellular carcinoma (HCC). However, the specific mechanism and potential clinical...
27.
Li H, Lu D, Chen J, Zhang J, Zhuo J, Lin Z, et al.
Int J Surg
. 2024 Feb;
110(4):2263-2274.
PMID: 38348848
Background: Highly active hepatitis B virus (HBV) is known to be associated with poor outcomes in patients with hepatocellular carcinoma (HCC). This study aims to investigate the relationship between HBV...
28.
Yang M, Shu W, Zhai X, Yang X, Zhou H, Pan B, et al.
Cell Mol Life Sci
. 2024 Feb;
81(1):83.
PMID: 38341383
Background And Aims: Due to a lack of donor grafts, steatotic livers are used more often for liver transplantation (LT). However, steatotic donor livers are more sensitive to ischemia-reperfusion (IR)...
29.
Qiu X, Dong L, Wang K, Zhong X, Xu H, Xu S, et al.
J Hepatocell Carcinoma
. 2024 Feb;
11:241-255.
PMID: 38333220
Background: Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide. Accumulating evidence indicates that hypoxia and lactate metabolism play critical roles in tumor progression and therapeutic efficacy....
30.
Chen Y, Meng L, Xu N, Chen H, Wei X, Lu D, et al.
Cell Commun Signal
. 2024 Feb;
22(1):95.
PMID: 38308318
Background: The remarkable regenerative capacity of the liver enables recovery after radical Hepatocellular carcinoma (HCC) resection. After resection, macrophages secrete interleukin 6 and hepatocyte growth factors to promote liver regeneration....